Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
11.25
-0.15 (-1.32%)
Oct 9, 2025, 4:00 PM EDT - Market closed
Avanos Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Net Income | -463.2 | -392.1 | -61.8 | 50.5 | 6.3 | -29 | Upgrade |
Depreciation & Amortization | 42.4 | 45.5 | 46.1 | 47.7 | 38.3 | 42.9 | Upgrade |
Stock-Based Compensation | 14.3 | 13.8 | 15.8 | 15.9 | 13.2 | 12.1 | Upgrade |
Other Adjustments | - | 437.9 | 72.7 | 1.1 | 8 | 23.7 | Upgrade |
Change in Receivables | 14.7 | -6.6 | 39 | -24.7 | -10.8 | 45.8 | Upgrade |
Changes in Inventories | 44.7 | 39 | 4.7 | -30.9 | 15.7 | -19.4 | Upgrade |
Changes in Accounts Payable | -2.5 | -0.9 | -14.4 | 35.4 | -11.9 | -18.9 | Upgrade |
Changes in Accrued Expenses | -22.7 | -11.4 | -27.7 | -7.1 | 33.4 | -74.3 | Upgrade |
Changes in Other Operating Activities | -29.2 | -24.5 | -42 | 3 | -4.9 | 14.6 | Upgrade |
Operating Cash Flow | 113.4 | 100.7 | 32.4 | 90.9 | 87.3 | -2.5 | Upgrade |
Operating Cash Flow Growth | 84.09% | 210.80% | -64.36% | 4.12% | - | - | Upgrade |
Capital Expenditures | -25.5 | -17.8 | -17.8 | -19.3 | -21 | -20.2 | Upgrade |
Purchases of Investments | -16.4 | -11.8 | - | - | - | -4 | Upgrade |
Payments for Business Acquisitions | - | - | -49.6 | -116.1 | - | - | Upgrade |
Proceeds from Business Divestments | - | 2.1 | 89 | - | - | - | Upgrade |
Investing Cash Flow | -41.9 | -27.5 | 21.6 | -135.4 | -21 | -24.2 | Upgrade |
Short-Term Debt Issued | - | 20 | 55 | 150 | 20 | 185 | Upgrade |
Short-Term Debt Repaid | - | -45 | -115 | -170 | -70 | -5 | Upgrade |
Net Short-Term Debt Issued (Repaid) | - | -25 | -60 | -20 | -50 | 180 | Upgrade |
Long-Term Debt Issued | - | - | - | 250 | - | - | Upgrade |
Long-Term Debt Repaid | -10.2 | -8.6 | -4.7 | -126.6 | - | -249.8 | Upgrade |
Net Long-Term Debt Issued (Repaid) | -10.2 | -8.6 | -4.7 | 123.4 | - | -249.8 | Upgrade |
Issuance of Common Stock | - | 1.1 | 1.3 | 1.7 | 6.2 | 3.4 | Upgrade |
Repurchase of Common Stock | -3.2 | -12.8 | -19.1 | -45.5 | -11.5 | -0.9 | Upgrade |
Net Common Stock Issued (Repurchased) | -3.2 | -11.7 | -17.8 | -43.8 | -5.3 | 2.5 | Upgrade |
Other Financing Activities | - | -3.8 | -11.7 | -2.9 | - | -2.7 | Upgrade |
Financing Cash Flow | -75.7 | -49.1 | -94.2 | 56.7 | -55.3 | -70 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 2.3 | -4.1 | 0.2 | -3 | -4 | 2.9 | Upgrade |
Net Cash Flow | -1.9 | 20 | -40 | 9.2 | 7 | -93.8 | Upgrade |
Beginning Cash & Cash Equivalents | 92.2 | 87.7 | 127.7 | 118.5 | 111.5 | 205.3 | Upgrade |
Ending Cash & Cash Equivalents | 90.3 | 107.7 | 87.7 | 127.7 | 118.5 | 111.5 | Upgrade |
Free Cash Flow | 87.9 | 82.9 | 14.6 | 71.6 | 66.3 | -22.7 | Upgrade |
Free Cash Flow Growth | 6.03% | 467.81% | -79.61% | 7.99% | - | - | Upgrade |
FCF Margin | 12.69% | 12.05% | 2.17% | 10.47% | 11.29% | -3.18% | Upgrade |
Free Cash Flow Per Share | 1.91 | 1.80 | 0.31 | 1.51 | 1.36 | -0.47 | Upgrade |
Levered Free Cash Flow | -466.2 | -395.8 | -177.6 | 182.7 | 5.9 | -174.1 | Upgrade |
Unlevered Free Cash Flow | 50.2 | -349.6 | -45.84 | 57.39 | 20.98 | -97.66 | Upgrade |
Updated Aug 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.